Progress to uncover the molecular and cellular regulators that govern human hematopoietic stem cell (HSC) fate has been impeded by an inability to obtain highly purified fractions of HSCs. We report that the rhodamine 123 (Rho 123) dye effluxing fraction of the Lin ؊ CD34 ؉ CD38 ؊ population contains SCID-repopulating cells (SRCs) capable of long-term repopulation in primary nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice. Purification based on Rho uptake led to a 4-fold enrichment of SRCs in the Lin ؊ CD34 ؉ CD38 ؊ fraction, with a frequency of 1 SRC in 30 Lin ؊ CD34 ؉ CD38 ؊ Rho lo cells. The Lin ؊ CD34 ؉ CD38 ؊ Rho lo fraction also possesses long-term selfrenewal capacity as measured by serial transplantation totaling more than 20 weeks.
Introduction
To identify factors that govern human hematopoietic stem cell (HSC) fate decisions (self-renewal or differentiation), pure HSC populations are required. Human HSCs are enriched in the Lin Ϫ CD34 ϩ CD38 Ϫ cell fraction, as assessed by the functional SCID-repopulating cell (SRC) assay. 1, 2 The frequency of SRCs in cord blood (CB) was estimated to be 1 in 600 Lin Ϫ CD34 ϩ CD38 Ϫ cells. 3 Recent improvements to the nonobese diabetic/severe combined immunodeficient (NOD/SCID) model have suggested that SRC frequency in this fraction is 1% to 2%. 4 Thus, while markedly enriched for HSCs, this fraction still remains heterogeneous. In the mouse, multiple markers are used to purify HSCs. One functional parameter used to purify HSCs is uptake of Rho. Rho is a fluorescent dye that binds to active mitochondria in cells, thus reflecting the metabolic state of the cell. [5] [6] [7] Rho efflux is mediated by P-glycoprotein, encoded by the multidrug resistance gene-1. 8 Murine long-term stem cells are enriched based on low retention of Rho. [9] [10] [11] Previous studies have attempted to separate human HSCs from progenitor cells using Rho, however, the SRC activity of purified fractions was not assessed. 8, 12 Here, we used the SRC assay to show that differential Rho efflux can be used to enrich human HSCs in the Lin Ϫ CD34 ϩ CD38 Ϫ cell fraction.
Materials and methods

NOD/SCID mouse repopulation
All animal experimental protocols were approved by the Animal Care Committee of the University Health Network. The NOD/SCID repopulation assay was performed by intrafemoral injection as described. 13, 14 Sublethally irradiated NOD/SCID mice (3.5 Gy) were treated with 200 g/mouse anti-CD122 antibody 24 hours prior to transplantation. 15 Mice were killed at 3 to 10 weeks after transplantation and the injected right femur (RF) and noninjected femur, tibia, and pelvis (BM) were analyzed by flow cytometry for human engraftment. Whole bone marrow from either RF or BM was injected into 2 separate preconditioned secondary mice, without further purification or adjustment for human-cell content. The transplanted cell dose from the RF and BM of mice that received a transplant of Lin Ϫ CD34 ϩ CD38 Ϫ Rho lo cells was 9.0 Ϯ 0.6 ϫ 10 6 and 29 Ϯ 2.6 ϫ 10 6 cells, respectively; and from the RF and BM of mice that received a transplant of Lin Ϫ CD34 ϩ CD38 Ϫ Rho hi cells was 7.5 Ϯ 1.1 ϫ 10 6 and 20.5 Ϯ 2.6 ϫ 10 6 cells, respectively.
Sample collection and purification
Samples of cord blood (CB) were obtained according to procedures approved by the institutional review board of Trillium Hospital and University Health Network. Human CB samples were depleted of lineagepositive and CD38 ϩ cells by negative selection using the StemSep system (Stem Cell Technologies, Vancouver, BC). Rho staining was performed as described. 9 Briefly, cells were incubated at 37°C in 0.1 g/mL rhodamine 123 dye (Eastman Kodak, Rochester, NY) for 30 minutes and destained at 37°C for an additional 30 minutes. CD38 and CD34 staining was performed as described. 12 Cells were sorted on a MoFlo (Dako Cytomation, Fort Collins, CO). Twenty percent cutoffs were used to sort Lin Ϫ CD34 ϩ CD38 Ϫ Rho lo and Lin Ϫ CD34 ϩ CD38 Ϫ Rho hi cell fractions as shown in Figure 1A . Sorted cells were injected at a dose of 3500 cells per mouse unless cells were injected for limiting dilution analysis (see "Limiting dilution analysis").
Lentivirus production, infection, and clonal analysis
A third-generation lentiviral vector encoding the enhanced green fluorescent protein (Egfp) gene was used for clonal tracking experiments as described. 13, 16 Lin Ϫ CD34 ϩ CD38 Ϫ Rho lo cells were infected at a concentration of 1.7 ϫ 10 5 cells/mL with an MOI of 130 to 180. Genomic DNA from the RF and BM of mice injected with transduced cells was extracted and clonal analysis was performed as reported. 16 Gene transfer efficiency (13.6%) was estimated in suspension cultures as described. 17 Submitted For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From
Limiting dilution analysis
Preconditioned mice received an intrafemoral transplant of 200, 100, or 50 Lin Ϫ CD34 ϩ CD38 Ϫ cells and 200, 100, or 33 Lin Ϫ CD34 ϩ CD38 Ϫ Rho lo cells along with 3000 irradiated (15 Gy) lineage-positive CB cells, and were killed after 7 to 10 weeks. Recipients were considered to be engrafted if the RF contained more than 0.4% CD45 ϩ human cells by flow cytometry or was positive by Southern blot analysis using a human-specific probe as described. 18 Data from 3 limiting dilution experiments (n ϭ 65 mice) were pooled and analyzed using L-Calc software (Stem Cell Technologies).
Statistical analysis
Data are presented as mean Ϯ standard error (SE). The significance of the differences between groups was determined by the Student t test (SigmaStat software; Jandel, Chicago, IL).
Results and discussion
Equivalent numbers of Lin Ϫ CD34 ϩ CD38 Ϫ Rho lo and Lin Ϫ -CD34 ϩ CD38 Ϫ Rho hi (hereafter referred to as Rho lo and Rho hi , respectively) cells were transplanted intrafemorally into preconditioned NOD/SCID mice, and human engraftment was evaluated at 3 and 7 weeks after transplantation ( Figure 1B and C, respectively) in the injected right femur (RF) and remaining bone marrow (BM: left femur, tibiae, and pelvis). This strategy enabled assessment of both repopulation and migration, properties characteristic of the most primitive SRCs. 19 At 3 weeks (Figure 1B) , Rho lo cells provided significantly higher levels of lymphomyeloid (CD45 ϩ ) engraftment in the RF than Rho hi cells (mean, 22.4% Ϯ 3.4% versus 8.7% Ϯ 3.5%), although only a trend was observed for the total human graft (CD45 ϩ lymphomyeloid and CD45 Ϫ CD36 ϩ GlyA ϩ erythroid cells). Similar to other grafts characterized at this early time point, 13 we observed high levels of CD45 Ϫ CD36 ϩ GlyA ϩ erythroid cells in the RF (mean, 37.4% Ϯ 5.6% and 22.5% Ϯ 8.5% from Rho lo and Rho hi cells, respectively). Comparable results were observed for engraftment in BM. By 7 weeks after transplantation ( Figure 1C) (Figure 2A ). The same trend was seen in secondary mice that received a transplant of primary BM cells ( Figure 2B ). To directly examine the self-renewal of individual Rho lo SRCs, we performed lentiviral-mediated clonal tracking for 3 primary mice and the corresponding 6 secondary mice. The presence of clones with the same restriction fragment size in primary mice that received a transplant of Rho lo cells and their secondary recipients ( Figure 2C ) Sorted cell populations were injected intrafemorally into preconditioned primary (1°) mice. After 7 to 10 weeks, the ability of SRCs to repopulate secondary (2°) mice was assessed separately for cells from the primary injected RF (A) and remaining BM (B). Secondary recipients were killed 7 to 10 weeks after transplantation, and human cell engraftment was assessed in the injected RF and remaining BM. Primary mice were injected with Lin Ϫ CD34 ϩ CD38 Ϫ Rho lo cells (F) Table link at the top of the online article). We defined the Rho lo fraction as the lower 20% of the Rho-stained Lin Ϫ CD34 ϩ CD38 Ϫ population. Therefore, if all stem cells were in the Rho lo fraction, the expected frequency would be 1 SRC in 24 Rho lo cells. Our estimated frequency of 1 SRC in 30 Rho lo cells indicates that most long-term repopulating cells are contained in this fraction. Thus, cell sorting based on Rho dye efflux provides an additional parameter for purification of human HSCs. Studies in the murine system suggest that purification of homogeneous HSC populations may not be possible as stem cells may be stochastically regulated by random intrinsic and extrinsic factors. 11 However, this improved protocol is a significant step toward achieving a more homogeneous population of primitive cells for both experimental and therapeutic applications.
